HomeAI · summaries
Storia in 3 fonti
Hetero Labs, Hungary’s Gedeon Richter to collaborate for Semaglutide
Semaglutide is the active ingredient in Novo Nordisk’s blockbuster diabetes and weight loss drugs Wegovy and Ozempic.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Gedeon Richter, Hetero Labs ink global pact for Semaglutide injection
Gedeon Richter and Hetero Labs form a global partnership to develop and commercialize Semaglutide Injection, enhancing diabetes treatment access.
- ·
economictimes.indiatimes.com
Hetero partners with Richter to develop, market Semaglutide injection globally
Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic of Ozempic. This collaboration aims to…
